Active Implants Enters Partnership with Geistlich Pharma AG for NUsurface® Meniscus Prosthesis
Active Implants LLC , a company that develops orthopedic implant solutions, today announced that it has reached an exclusive agreement with Geistlich Pharma AG to be the exclusive Swiss distributor of the companys NUsurface Meniscus Prothesis.
- Active Implants LLC , a company that develops orthopedic implant solutions, today announced that it has reached an exclusive agreement with Geistlich Pharma AG to be the exclusive Swiss distributor of the companys NUsurface Meniscus Prothesis.
- The relationship between Active Implants and Geistlich Pharma began in 2019 with the launch of the MEFISTO project.
- The NUsurface is the first artificial meniscus to be marketed in Europe and is currently under review by the U.S. Food and Drug Administration (FDA).
- Geistlich Pharma AG is a Swiss company, owned by the family Geistlich with its headquarters in Central Switzerland in Wolhusen and in Root.